Goldman Sachs’s Zai Lab ZLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ZLAB
RI
RCM
FLSM
ACM
RSCM
CWG
Goldman Sachs's ZLAB Position: Q1 2026 in Review
Goldman Sachs reduced its Zai Lab (ZLAB) stake by 26% in Q1 2026, selling an estimated $720K and leaving 110,587 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4508.
Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 32 quarters since. The position peaked at $87.8M in Q3 2020. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.
- Goldman Sachs held 110,587 shares of Zai Lab worth $2.08M as of Q1 2026.
- Goldman Sachs sold 38,847 Zai Lab shares in Q1 2026, an estimated $720K.
- Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4508 holding.
- Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 32 quarters since.
- Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
- 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.